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This document summarizes the rationale, equipment, measurement, protocol and data cleaning 
procedures for each of the cardiovascular measures collected at the Wave V home exam. It also 
documents how constructed variables were derived from the cardiovascular measures collected in the 
field.   Whenever possible, data collection and methods in Wave V mirrored those of Wave IV to ensure 
comparability of data between waves. This document is one in a set of Wave V user guides. User guides 
are also available to describe protocols for the following biological measures in Wave V: 
 Anthropometrics 
 Medication Use 
 Baroreflex Sensitivity & Hemodynamic Recovery 
 Glucose Homeostasis 
 Inflammation and Immune Function 
 Lipids 




This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and 
designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North 
Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, with cooperative funding from 23 other federal 
agencies and foundations. We gratefully acknowledge Carolyn Halpern, Nancy Dole, Joyce Tabor, and 
Sarah Dean for their dedication to the quality of the Add Health data in this document. Information on 





Citations of this Add Health User Guide should use the following format: 
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Cardiovascular Measures, 2020; Available from: https://doi.org/10.17615/gtme-ag52 
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1. Introduction 
 
The cardiovascular measures collected at Add Health Wave IV were also collected at the Wave V home 
exam in the following order: 
 
• Arm Circumference (cm) 
• Systolic blood pressure (SBP, mm Hg)  
• Diastolic blood pressure (DBP, mm Hg)  
• Pulse rate (PR, beats/min)  
 
In addition, the Add Health Wave V cardiovascular data set includes nine constructed measures based 
on information collected at the home exam:    
  
• Average systolic blood pressure 
• Average diastolic blood pressure 
• Average pulse rate 
• Pulse pressure (mm Hg) 
• Mean arterial pressure (mm Hg)  
• Blood pressure classification based on JNC7 
• Blood pressure classification based on AHA/ACC 
• Antihypertensive medication use 
• Joint classification of average blood pressures, history of health care provider-diagnosed high 
blood pressure, and antihypertensive medication use 
 
2. General Overview of Data Collection 
 
2.1. Biomarker Consent & Scheduled Home Exam  
 
At the end of the Wave V Survey, respondents were asked if they would agree to participate in the Wave 
V home exam administered by a field examiner (FE), which included taking measurements and collecting 
a blood sample.  If the participant agreed, examiners from the Add Health data collection partner 
(Section 2.2) scheduled a date and time for the home exam.  Depending on participant and/or FE 
availability, the time between the Wave V Survey completion and the home exam ranged from days to 
years (see the time interval variable H5TIMESE in the bdemo5 data set and codebook).  Some 
respondents completed the home exam before completing the entire Wave V Survey, resulting in a 
negative time interval.  There were two scenarios where this occurred:  
a) Sample 1 respondents selected for administration of the modular questionnaire were asked to 
complete the biomarker consent section after completing Module A of the Web Questionnaire 
and Mail Questionnaire. These respondents could consent to and complete the home exam 
before continuing to complete Module B.1 
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b) Respondents who completed the Sample 1 non-response follow up (NRFU) abbreviated 
telephone interview could consent to and complete the home exam before completing the full 
Wave V Survey.1 
2.2. Home Exam 
 
All data were collected during home exams performed by FEs from two Add Health data collection 
partners: Examination Management Services, Inc. (2016-2017) and Hooper Holmes, Inc. (2018-2019). All 
FEs were trained and certified using a custom program specific to the Add Health protocol. FEs used a 
7” Samsung Galaxy Tab 4 tablet to record and transmit data. An Add Health data collection application 
(Open Data Kit or ODK) installed on the tablet guided the FEs through the home exam protocol. In 
addition, FEs received a series of job aids, both on paper and on the tablet, to serve as quick reference 
guides when completing the protocol. Each tablet also contained an in-depth Add Health training 
manual that could be accessed at any time. 
 
Once the home exam was initiated, a few preliminary questions were asked of respondents and then 
cardiovascular measures were collected. Respondents were free to skip any portion of the data 
collection or terminate the visit at any time. Particular care was taken to provide respondents with 
written documentation of mean blood pressures and current guideline-based recommendations for 
follow-up.  
 




Arm circumference was measured to guide selection of an appropriately sized blood pressure cuff for 




FEs used a SECA 201 metric-increment circumference soft tape measure (Seca Corp., North 
America East; Hanover, MD) to measure arm circumference (Exhibit 1). 
 
Specifications:   
• 200 cm maximum range  
• 1 mm graduations  
• 2-sided cm scaling  
• 90 x 25 x 65 mm   
• 50 g  
• Fiberglass tape  
• Plastic case  
• Automatic roll-up  
• End-peg positioned  
 Exhibit 1. SECA 201 tape measure 
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3.3 Measurement and Protocol 
 
Trained and certified FEs measured right arm circumference and blood pressure unless one or more of 
the following contraindications was present:    
  
• open sores, wounds, gauze dressings or rashes;  
• casts, splints or shunts;  
• intravenous (IV) catheters or other attached medical devices;  
• swelling, withering or paralysis; or  
• arm on same side as prior mastectomy.    
  
If there were contraindications to the measurement of right arm circumference or blood pressure, FEs 
measured left arm circumference.  If there were contraindications to measurement on both arms, arm 
circumference and blood pressure were not measured.       
  
To measure arm circumference accurately, FEs asked respondents to remove bulky outer garments (e.g., 
sweaters or jackets) and, if applicable, push up their shirt sleeves to expose the upper arm.  FEs also 
instructed respondents to relax their shoulders and allow their arm to be measured while hanging 
loosely at their side. FEs wrapped the SECA tape around the respondent’s upper arm, midway between 
the shoulder and elbow. Arm circumference was measured to the nearest 0.5 cm and entered into the 
tablet which determined the appropriate cuff size for blood pressure measurement. Determination of 
cuff size and blood pressure measurement differed before and after the 2017-2018 transition between 
data collection partners (Exhibit 2): 
 
Arm 2016-2017 2018-2019 
Circumference BP Cuff Size BP Cuff Size 
< 24.0 cm X X  Adult 
24.0-29.9 cm  Adult  Adult 
30.0-40.5 cm  Large Adult  Large Adult 
> 40.5 cm X X X X 
     
Exhibit 2.  Cuff Size and Blood Pressure Measurement 
 
3.4 Data Cleaning 
Arm circumferences entered in inches were converted to centimeters. The skip logic and distribution of 
the entered arm circumferences were checked for outliers and inconsistencies. Outlying measured arm 
circumferences were identified using an extreme studentized deviate (ESD) multiple outlier detection 
procedure.2 All outliers identified as described above were investigated for inconsistencies within Wave 
V. Clearly inconsistent Wave V arm circumferences were recoded to “invalid data” (H5ARMCIR=9999).  
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4. Cardiovascular Measures 
 
4.1 Rationale  
 
Blood pressure and pulse rate were measured because of their established relationship with 




FEs used a factory calibrated, Microlife BP3MC1-PC-IB oscillometric blood pressure monitor (MicroLife 
USA, Inc.; Dunedin, FL) recommended for clinical and home use by the British Hypertension Society 
(Exhibit 3) and an Adult or Large Adult cuff to measure blood pressure and pulse rate.   Specifications:   
 
• Weight: 735 g (with batteries)  
• Size: 160 (W) x 140 (L) x 98 (H) mm  
• Storage Temperature: 20°C-50°C (-4°F -122°F)  
• Humidity: 15%-90% relative humidity maximum  
• Operation Temperature: 10°C-40°C (50°F-104°F)  
• Display: Liquid crystal display (LCD)  
• Measuring Method: Oscillometric  
• Pressure Sensor: Capacitive  
• Measuring Range: 30-280 mmHg (SBP and DBP); 40 to 200 beats/min (PR)  
• Cuff Pressure Display Range: 0-299 mmHg  
• Measuring Resolution: 1 mmHg  
• Accuracy: ±3 mmHg (SBP & DBP); ±5 % (PR)  
• Power Source: [1] 4 AA batteries, 1.5V [2] AC Adapter 6V DC 600 mA (4.5-6 V DC) 
• Adult Cuff (S101, for arm circumferences: 9.5-13.25 in) 
• Large Adult Cuff (S102, for arm circumferences: 12-16 in)   
Exhibit 3. Microlife blood pressure monitor 
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4.3 Measurement 
 
Trained and certified FEs measured resting, seated systolic and diastolic blood pressure (mmHg) and 
pulse rate (beats/minute).  Three serial measurements were collected separated by at least 30-second 
intervals.  Readings from the display on the BP monitor were keyed into the tablet ODK. Variable names 
were as listed in Exhibit 4. 
 
Measure Variable Measure Variable Measure Variable 
SBP #1 Q031 DBP #1 Q032 PR #1 Q033 
SBP #2 Q036 DBP #2 Q037 PR #2 Q038 
SBP #3 Q041 DBP #3 Q042 PR #3 Q043 
      




FEs used the Microlife blood pressure monitor supplied by Add Health unless unable to do so. When an 
alternate monitor was used, the reason was recorded in the tablet (occurred in 20 [0.4%] of the 5,381 
exams).  
  
Respondents who left their seat for any reason during the five minutes before blood pressure 
measurement were reseated. All respondents rested with both feet on the floor and legs uncrossed for 
five minutes before and during blood pressure measurement.  FEs positioned the Microlife monitor 
display so that it was outside the view of respondents.    
  
FEs collected three measurements of blood pressure and pulse rate separated by at least 30 second 
intervals.  During each interval, respondents raised their elbow to the level of the shoulder and held the 
forearm upward at a 90-degree angle for five seconds after which the tablet presented a 20 second 
countdown ending in a visual cue and audible chime to prompt the next measurement.  Immediately 
following each of the three measurements, FEs keyed the systolic and diastolic blood pressures and 
pulse rate into the tablet ODK.  
  
In the event of a measurement error, FEs keyed the error message code from the Microlife display into 
the tablet ODK. The tablet returned the appropriate, i.e. manufacturer-recommended solution to the 
FE, who then implemented it and repeated the measurement. In the uncommon event of a recurring 
measurement error, it also was keyed into the tablet ODK, the remaining measurements were skipped, 
the FE stopped using the monitor, and contacted the field supervisor. All malfunctioning monitors and 
cuffs were immediately withdrawn from fieldwork and replaced.    
 
Using average blood pressure measures as well as self-reported pregnancy status, smoking status, and 
history of health care provider-diagnosed cardiovascular risk factors, the tablet ODK provided current 
guideline-based recommendations for (1) follow-up with a health care provider,3,4 (2) skipping the blood 
draw, and / or (3) halting the visit.  When mean SBP and DBP did not fall within the same follow-up 
category, the earlier follow-up was recommended.  When mean SBP and DBP warranted follow up 
within one day, the tablet ODK prompted FEs to immediately terminate the home exam and stay with 
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respondents for up to 30 minutes while they called a health care provider, friend or relative to discuss 
the results (occurred in  22 [0.4%] of the 5,381 respondents).  As tabulated below in Exhibits 5 and 6, 















<120 AND <80 NA 2 years Yes No 
120-139 OR 80-89 NA 1 year Yes No 
140-159 OR 90-99 NA 2 months Yes No 
160-179 OR 100-109 NA 1 month Yes No 
180-199 OR 110-119 Negative 1 week Yes No 
180-199 OR 110-119 Positive 1 day No Yes 
>199 OR >119 NA 1 day No Yes 
Follow-up based on the Seventh Report of the Joint National Committee on Prevention 
Detection, Evaluation, and Treatment of High Blood Pressure.3   *Average of SBP #2 & #3 
(mm Hg) [Variable: H5SBP].   †Average of DBP #2 & #3 (mm Hg) [Variable: H5DBP].  ‡ Self-
reported pregnancy – known or not known [Variable: H5Q012 = 1 or 98] or currently 
smoke [Variable: H5Q015 = 1] or history of health care provider-diagnosed high blood 
pressure [Variable: H5Q045A = 1], diabetes [Variable: H5Q045B = 1], heart disease 
[Variable: H5Q045C = 1], chronic kidney disease [Variable: H5Q045D = 1], stroke 
[Variable: H5Q045E = 1] or high cholesterol or triglycerides [Variable: H5Q045F = 1].  NA = 
not applicable. 




 (mm Hg) 
 DBP† 









<120 AND <80 NA 1 year Yes No 
120-129 AND <80 NA 3-6 months Yes No 
130-139 OR 80-89 Negative 3-6 months Yes No 
130-139 OR 80-89 Positive 1 month Yes No 
140-180 OR 90-120 NA 1 month Yes No 
>180 OR >120 NA 1 day No Yes 
Follow-up based on the Guideline for the Prevention, Detection, Evaluation, and 
Management of High Blood Pressure in Adults from the American Heart 
Association/American College of Cardiology Task Force.4 *Average of SBP #2 & #3 (mm Hg) 
[Variable: H5SBP].  †Average of DBP #2 & #3 (mm Hg) [Variable: H5DBP].  ‡ Self-reported 
pregnancy – known or not known [Variable: H5Q012 = 1 or 98] or currently smoke 
[Variable: H5Q015 = 1] or history of health care provider-diagnosed high blood pressure 
[Variable: H5Q045A = 1], diabetes [Variable: H5Q045B = 1], heart disease [Variable: 
H5Q045C = 1], chronic kidney disease [Variable: H5Q045D = 1], stroke [Variable: H5Q045E = 
1] or high cholesterol or triglycerides [Variable: H5Q045F = 1].  NA = not applicable. 
Exhibit 6.  2018-2019 Recommendations for Follow-up, Blood Draw, and Visit 
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FEs transferred the follow-up recommendation to a “Cardiovascular Health Sheet” and gave it to 
respondents after the home exam.  The sheet included the date of the home exam, mean systolic and 
diastolic blood pressures warranting the follow-up recommendation, information about risk factors for 
heart disease, and contact information for the American Heart Association. 
 
4.5 Data cleaning  
  
Blood pressure and pulse rate were double keyed, automatically compared, and range checked at the 
time of entry into the tablet ODK to prevent keystroke errors. They also were plotted over time, 
statistically summarized, and reviewed weekly throughout Wave V to monitor missing data, outliers, 
digit preference, and short-term reliability.  Moreover, repeated measures were compared for 
consistency. 
 
5. Constructed Variables 
 
For the following constructed variables that are based on the blood pressure and pulse rate collected 
three times during the visit, the final calculations were made using measures 2 and 3 whenever possible. 
When either measure 2 or 3 was missing, the other single measure was used in the calculation.  In cases 
when both measures 2 and 3 were missing, measure 1 was used in the calculation.  The variable, called 
H5BPFLG, flags which measures were used in the construction of each of these calculated variables.   
 
5.1 Average systolic blood pressure (mm Hg) [H5SBP] 
 
Average systolic blood pressure was constructed as the mean of systolic blood pressures 2 and 3.  When 
either measure 2 or 3 was missing, the systolic blood pressure for the other single measure was used.  In 
cases when both measures 2 and 3 were missing, systolic blood pressure 1 was used.   
 
5.2 Average diastolic blood pressure (mm Hg) [H5DBP] 
 
Average diastolic blood pressure was constructed as the mean of diastolic blood pressures 2 and 3.  
When either measure 2 or 3 was missing, the diastolic blood pressure for the other single measure was 
used.  In cases when both measures 2 and 3 were missing, diastolic blood pressure 1 was used.   
 
5.3 Average pulse rate (beats/min) [H5PR] 
 
Average pulse rate was constructed as the mean of pulse rates 2 and 3.  When either measure 2 or 3 
was missing, the pulse rate for the other single measure was used.  In cases when both measures 2 and 
3 were missing, pulse rate 1 was used.   
 
5.4 Pulse pressure (mm Hg) [H5PP] 
  
Pulse pressure was constructed as the average of the difference between systolic and diastolic blood 
pressures using measures 2 and 3.  When either measure 2 or 3 was missing, the difference between 
systolic and diastolic blood pressure for the other single measure was used.  In cases when both 
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measures 2 and 3 were missing, the difference between the systolic and diastolic blood pressure 1 was 
used.  The formula is:   
  
((SBP2 - DBP2) + (SBP3 - DBP3))/2 
  
5.5 Mean arterial pressure (mm Hg) [H5MAP] 
  
Mean arterial pressure was conventionally approximated as the weighted sum of systolic and diastolic 
blood pressure measures 2 and 3, where the weights for SBP (1/3) and DBP (2/3) reflect the typical 
contributions of ventricular systole and diastole to the duration of the cardiac cycle. When either 
measure 2 or 3 was missing, the other single measure was used.  In cases when both measures 2 and 3 
were missing, the first measure was used.  The formula is:   
  
(((SBP2 + (2*DBP2))/3) + ((SBP3 + (2*DBP3))/3))/2 
 
 
5.6 Blood pressure classification based on JNC7 [H5BPCLS4] 
  
Classification of average blood pressures was based on guidelines from the Seventh Report of the Joint 











Normal <120 AND <80 1 
Pre-hypertension 120-139 OR 80-89 2 
Hypertension Stage 1  140-159 OR 90-99 3 
Hypertension Stage 2  ≥ 160 OR ≥ 100 4 
     
Exhibit 7.  JNC7 Classification of Blood Pressure 
 
5.7 Blood pressure classification based on AHA/ACC [H5BPCLS5] 
 
Classification of average blood pressures also was based on the Guideline for the Prevention, Detection, 
Evaluation, and Management of High Blood Pressure in Adults from the American Heart 





 (mm Hg) 
 H5DBP 
 (mm Hg) 
 
H5BPCLS5 
Normal <120 AND <80 1 
Elevated 120-129 AND <80 2 
Hypertension Stage 1  130-139 OR 80-89 3 
Hypertension Stage 2  140-180 OR 90-120 4 
Hypertension Crisis >180 OR >120 5 
     
Exhibit 8.  AHA/ACC Classification of Blood Pressure 
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5.8 Antihypertensive medication use [H5AHT] 
 
Use of a prescription medication in the past 4 weeks in one or more of the therapeutic classes listed in 
Exhibit 9 was assigned a value of 1.  Non-use of a prescription medication in the past four weeks in one 
of the therapeutic classes listed below was assigned a value of 0. 
 
Class Label Variable 
040-042-xxx Angiotensin converting enzyme (ACE) inhibitors 
H5AHT 
040-043-xxx  Anti-adrenergic agents (peripherally acting) 
040-044-xxx  Anti-adrenergic agents (centrally acting) 
040-047-xxx  Beta-adrenergic blocking agents 
040-048-xxx  Calcium channel blocking agents 
040-049-156  Thiazide diuretics 
040-053-xxx  Vasodilators 
040-055-xxx  Antihypertensives 
040-056-xxx  Angiotensin II (AT2) inhibitors 
   
Exhibit 9.  Antihypertensive Medication Use 
 
Therapeutically classified use of prescription medication in particular classes may confound biomarker-
based estimates of disease prevalence or risk. For example, use of antihypertensive medications may 
confound blood pressure-based estimates of hypertension prevalence or cardiovascular disease risk. 
However, the (1,0) classifications should be used cautiously in the investigation or control of potential 
confounding, because selection biases often threaten the study of non-randomized medication 
exposures. 
 
5.9 Joint Classification of Hypertension [H5HTENJC]  
 
Respondents were flagged as having evidence of hypertension when they met at least one of the 
following criteria in Exhibit 10:  
 
Criterion (≥ 1 of the following must be true) Variable & Value 
JNC7 Hypertension Stage 1 or 2 H5BPCLS4=3 or 4 
Self-reported history of diagnosed high blood pressure H5Q045A=1 
Antihypertensive medication use in the past 4 weeks H5AHT=1 
 
Exhibit 10. Criteria Used to Identify Hypertension 
 
The criteria are analogous to those adopted at Wave IV,5,6 in that they rely only on contemporaneous 
information collected at the home exam and the JNC classification. 
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6. Quality Control 
 
6.1.  Equipment Evaluation and Accuracy 
 
To ensure it was in working order, all field equipment was evaluated before study start-up in 2016 and 
during the 2017-2018 transition between data collection partners. 
 
6.2.  Digit Preference 
FE-specific digit preference was monitored throughout fieldwork using a Pearson χ2 test of the null 
hypothesis that all possible digits (0, 1, 2, …, 9) were observed with equal frequency and a digit 
preference score (DPS).7  As at Add Health Wave IV, there was little evidence of penultimate digit 
preference in FE recording of measured arm circumference (DPS: 1.9) or terminal digit preferences in 
recording of blood pressures or pulse rates (DPS range: 1.9–3.5). There was, however, some evidence of 
whole- and half-unit rounding of terminal digits for arm circumferences despite FE training aimed at 
eliminating it (DPS: 65.3).8 
6.3.  Reliability 
Within a race/ethnicity- and sex-stratified random sample of 112 Add Health respondents among whom 
cardiovascular measures were collected twice, on average 14.1 (95% confidence interval: 13.0–15.3) 
days apart, typically by the same FE and at approximately the same time of day, the reliability of arm 
circumference, blood pressures and pulse rates was estimated as an intra-class correlation coefficient 
(ICC, 95% confidence interval) (Exhibit 11). The estimates (range: 0.65–0.86) reflected those stemming 
from Add Health Wave IV and suggested that home exam cardiovascular measures are comparably 
reliable at Add Health Wave V.8 
Measure N ICC 95% CI 
Arm (cm) 112 0.86 (0.82,0.91) 
SBP #1  111 0.72 (0.62,0.81) 
SBP #2 112 0.65 (0.54,0.75) 
SBP #3 112 0.70 (0.60,0.79) 
Average SBP 112 0.72 (0.64,0.81) 
DBP #1 111 0.71 (0.62,0.80) 
DBP #2 112 0.67 (0.56,0.77) 
DBP #3 112 0.67 (0.57,0.77) 
Average DBP 112 0.71 (0.62,0.80) 
PR #1 111 0.69 (0.60,0.79) 
PR #2 112 0.67 (0.56,0.77) 
PR #3 112 0.70 (0.60,0.79) 
Average PR 112 0.72 (0.63,0.81) 
    
Exhibit 11.  Reliability of cardiovascular measures 
 
Add Health is a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the 
University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and 
Human Development, with cooperative funding from 23 other federal agencies and foundations. Information on how to obtain the Add Health data files is 
available on the Add Health website (http://www.cpc.unc.edu/addhealth). 
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The structure of the disseminated cardiovascular data file is flat.  This means that it is a respondent-level 
data file, wherein each respondent has one and only one record.  The respondent identifier (AID) will 




The cardiovascular data file includes the variables below, which are described in the corresponding 
codebook documentation that also contains frequencies.  
 
Variable Name Variable Description 
AID Respondent Identifier 
H5Q015 Q015 Currently smoke tobacco products 
H5ARM Q023 Which arm is measured 
H5ARMCIR Measured arm circumference (cm) 
H5ARMINS Flag indicates arm measure was converted from inches to cms 
H5CUFFIT Flag indicates if the arm fit the BP cuff 
H5Q031 Q031 Systolic blood pressure #1 (MMHg) 
H5Q032 Q032 Diastolic blood pressure #1 (MMHg) 
H5Q033 Q033 Pulse rate #1 (/Min) 
H5Q036 Q036 Systolic blood pressure #2 (MMHg) 
H5Q037 Q037 Diastolic blood pressure #2 (MMHg) 
H5Q038 Q038 Pulse rate #2 (/Min) 
H5Q041 Q041 Systolic blood pressure #3 (MMHg) 
H5Q042 Q042 Diastolic blood pressure #3 (MMHg) 
H5Q043 Q043 Pulse rate #3 (/Min) 
H5BPFLG Number of BP/PR measures used to for single measure 
H5SBP Average systolic blood pressure (MMHg) 
H5DBP Average diastolic blood pressure (MMHg) 
H5BPCLS5 Blood pressure classification based on AHA/ACC 
H5BPCLS4 Blood pressure classification based on JNC7 
H5PR Average pulse rate (/Min) 
H5PP Pulse pressure (MMHg) 
H5MAP Mean arterial pressure (MMHg) 
H5Q045A Q045a Ever diagnosed with high blood pressure or hypertension 
H5Q045B Q045b Ever diagnosed with diabetes 
H5Q045C Q045c Ever diagnosed with heart attack or heart surgery 
H5Q045D Q045d Ever diagnosed with kidney disease or failure 
H5Q045E Q045e Ever diagnosed with stroke or mini-stroke 
H5Q045F Q045f Ever diagnosed with high cholesterol or triglycerides 
H5AHT Flag indicates antihypertensive medication use in past 4 weeks 
H5HTENJC Hypertension joint classification 
  
Add Health is a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the 
University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and 
Human Development, with cooperative funding from 23 other federal agencies and foundations. Information on how to obtain the Add Health data files is 
available on the Add Health website (http://www.cpc.unc.edu/addhealth). 
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